TNF and breast cancer: Askling and colleagues [5] presented SIRs for various solid tumors and reported no difference in patients with RA who received anti-TNF medication compared with the general population for lung and colorectal cancer, whereas the SIR for breast cancer was decreased (SIR 0.4, 95% CI 0.2 to 0.9).